The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications

Lancet
Jessica R AllegrettiMonika Fischer

Abstract

Developments in high-throughput microbial genomic sequencing and other systems biology techniques have given novel insight into the potential contribution of the gut microbiota to health and disease. As a result, an increasing number of diseases have been characterised by distinctive changes in the composition and functionality of the gut microbiota; however, whether such changes are cause, consequence, or incidental to the disease in question remains largely uncertain. Restoration of the gut microbiota to a premorbid state is a key novel therapeutic approach of interest, and faecal microbiota transplantation-the transfer of prescreened stool from healthy donors into the gastrointestinal tract of patients-is gaining increasing importance in both the clinical and research settings. At present, faecal microbiota transplantation is only recommended in the treatment of recurrent Clostridioides difficile infection, although a large number of trials are ongoing worldwide exploring other potential therapeutic indications.

Citations

Nov 15, 2019·Current Opinion in Nephrology and Hypertension·Gianvito CaggianoLoreto Gesualdo
Dec 18, 2019·Clinical Chemistry·Robert Schlaberg
Mar 7, 2020·Pediatric Blood & Cancer·Ronald D Barr, Michael C G Stevens
Jul 14, 2020·Alimentary Pharmacology & Therapeutics·Jonathan P SegalTariq H Iqbal
Jul 4, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chuanhai ZhangKunlun Huang
Jun 12, 2020·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Béatrice S-Y ChoiAngelo Tremblay
Aug 19, 2020·Journal of Crohn's & Colitis·Scott W Olesen, Ylaine Gerardin
Jul 18, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jay WorleyLynn Bry
Dec 6, 2019·Annals of Medicine·Jarmo OksiEero Mattila
Jun 11, 2020·Journal of Clinical Medicine·Stefano BibbòAntonio Gasbarrini
Feb 8, 2020·Current Infectious Disease Reports·Erin H Graf, Preeti Pancholi
Sep 12, 2020·Science·Jennifer A Wargo
Jan 30, 2020·Frontiers in Immunology·Paola C L LeocádioJacqueline I Alvarez-Leite
Dec 10, 2019·Science China. Life Sciences·Xueying ZhangNing Li
Dec 19, 2019·Alimentary Pharmacology & Therapeutics·Eamonn M M Quigley
Mar 31, 2020·Journal of Gastroenterology·Mette Vesterhus, Tom Hemming Karlsen
Jul 15, 2020·Immunological Medicine·Katsuyoshi Matsuoka
Sep 22, 2020·Therapeutic Advances in Gastroenterology·Jonathan P SegalHarry Sokol
Oct 10, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Ethan G Brown, Samuel M Goldman
Oct 27, 2020·British Journal of Nursing : BJN·James L Alexander, Benjamin H Mullish
Nov 10, 2020·Cancer Immunology, Immunotherapy : CII·Fausto Meriggi, Alberto Zaniboni
Nov 12, 2020·The Journal of Experimental Medicine·Allyson L ByrdUNKNOWN Milieu Intérieur Consortium
Nov 25, 2020·Clinical Epigenetics·Nuno R NenéMartin Widschwendter
Sep 30, 2020·Nursing Research·Katherine A MakiGwenyth R Wallen
Nov 28, 2020·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Christopher J Hernandez
Dec 20, 2020·Cell·Carlos López-Otín, Guido Kroemer
Dec 12, 2020·Computational and Structural Biotechnology Journal·Maozhen HanKang Ning
Jul 10, 2020·EClinicalMedicine·Christian Lodberg HvasChristian Erikstrup
Nov 3, 2020·World Journal of Gastroenterology : WJG·Quan WenFa-Ming Zhang
Nov 17, 2020·Frontiers in Immunology·Eric MariettaJoseph A Murray

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Related Papers

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Cole KrenskySusy S Hota
Therapeutic Advances in Gastroenterology
Shaan GuptaElaine O Petrof
Advances in Experimental Medicine and Biology
Marcello MaidaG Cammarota
© 2021 Meta ULC. All rights reserved